Reports on an approach to the treatment of autoimmune and other immune mediated-diseases whereby genetically modified T cells expressing a peptide-major histocompatibility complex (MHC) complex inhibit the disease-inducing T cells and protect mice from the development of an autoimmune disease. Study by Geiger et al.